Atosiban

CAS No.	90779-69-4	Cat. No.	BCP02053
Name	Atosiban
Synonyms	Tractocile;ORF-22164; ORF 22164; ORF22164; RWJ-22164; RWJ 22164; RWJ22164;
Formula	C43H67N11O12S2	M. Wt	994.19

Description	Atosiban, also known as ORF 22164, RWJ 22164, is an inhibitor of the hormones oxytocin and vasopressin. It is used as an intravenous medication as a labour repressant (tocolytic) to halt premature labor. Although initial studies suggested it could be used as a nasal spray and hence would not require hospital admission, it is not used in that form. It was developed by Ferring Pharmaceuticals in Sweden and first reported in the literature in 1985. Originally marketed by Ferring Pharmaceuticals, it is licensed in proprietary and generic forms for the delay of imminent pre-term birth in pregnant adult women.
Pathways	GPCR/G Protein
Targets	Oxytocin Receptor

Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.

For product details of different batches, please contact our Customer

Products are for research use only and not for human use. We do not sell to patients.